Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid β

Journal of Neurochemistry

Volumn 69, Issue 5, 1997, Pages 1995-2004

  Martel, Cynthia L ^a   Mackic, Jasmina B ^a   Matsubara, Etsuro ^b   Governale, Samuel ^b   Miguel, Calero ^b   Miao, Wesley ^a   McComb, J Gordon ^a   Frangione, Blas ^b   Ghiso, Jorge ^b   Zlokovic, Berislav V ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Apolipoprotein E; Blood brain barrier; Cerebrovascular sequestration; Permeability

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CAPILLARY PERMEABILITY; CHOROID PLEXUS; GUINEA PIG; NONHUMAN; PRIORITY JOURNAL; PROTEIN POLYMORPHISM;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0030779128     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69051995.x     Document Type: Article

References (58)

1. Banks W. A. and Kastin A. J. (1996) Passage of peptides across the blood-brain barrier: pathophysiological perspectives. Life Sci. 59, 1923-1943.
2. Berr C., Hauw J.-J., Delaere P., Duyckaerts C., and Amouyel P. (1994) Apolipoprotein E allele ∈4 is linked to increased deposition of the amyloid-β peptide (Aβ) in cases with or without Alzheimer's disease. Neurosci. Lett. 178, 221-224.
3. Bertrand P., Poirier J., Oda T., Finch C. E., and Pasinetti G. M. (1995) Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Mol. Brain Res. 33, 174-178.
4. Biere A. L., Ostaszewski B., Stimson E. R., Hyman B. T., Maggio J. E., and Selkoe D. J. (1996) Amyloid β-peptide is transported on lipoproteins and albumin in human plasma. J. Biol. Chem. 271, 32916-32922.
5. Busciglio J., Gabuzda D. H., Matsudaira P., and Yankner B. A. (1993) Generation of β-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. Natl. Acad. Sci. USA 90, 2092-2096.
6. Castaño E. M., Prelli F., Golabek R., Kumar A., Soto C., and Frangione B. (1995) Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E. Biochem. J. 306, 599-604.
7. Castaño E. M., Prelli F., Soto C., Beavis R., Matsubara E., Shoji M., and Frangione B. (1996) The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-β 1-42 in Alzheimer's disease. J. Biol. Chem. 271, 32185-32191.
8. Chan W., Fornwald J., Brawner M., and Wetzel R. (1996) Native complex formation between apolipoprotein E isoforms and the Alzheimer's disease peptide Aβ. Biochemistry 35, 7123-7130.
9. Citron M., Diehl T. S., Gordon G., Biere A. L., Seubert P., and Selkoe D. J. (1996) Evidence that the 42- and 40-amino acid forms of amyloid β protein are generated from the β-amyloid precursor protein by different protease activities. Proc. Natl. Acad. Sci. USA 93, 13170-13175.
10. Dickson D. W. (1997) The pathogenesis of senile plaques. J. Neuropathol. Exp. Neural. 56, 321-339.
11. El Khoury J., Hickman S. E., Thomas C. A., Cao L., Silverstein S. C., and Loike J. D. (1996) Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature 382, 716-719.
12. Evans K. C., Berger E. P., Cho C. G., Weisgraber K. H., and Lansbury P. T. Jr. (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 92, 763-767.
13. Ghersi-Egea J.-F., Gorevic P. D., Ghiso J., Frangione B. F., Patlak C. S., and Fenstermacher J. D. (1996) Fate of cerebrospinal fluid-borne amyloid β-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries. J. Neurochem. 67, 880-883.
14. 1-40 labels amyloid deposits in the aged primate brain in vivo. Neuroreport 7, 2607-2611.
15. Ghiso J., Matsubara E., Koudinov A., Choi-Miura N.-H., Tomita M., Wisniewski T., and Frangione B. (1993) The cerebrospinal fluid soluble form of Alzheimer's amyloid β is complexed to SP40,40 (ApoJ), an inhibitor of the complement membrane attack complex. Biochem. J. 293, 27-30.
16. Ghiso J., Wisniewski T., and Frangione B. (1994) Unifying features of systemic and cerebral amyloidosis. Mol. Neurobiol. 8, 49-64.
17. Glass C. K., Pittman R. C., Keller G. A., and Steinberg D. (1983) Tissue sites of degradation of apoprotein A-I in the rat. J. Biol. Chem. 258, 7161-7167.
18. Guillaume D., Dea D., Davignon J., and Poirer J. (1995) Low-density lipoprotein pathways in the central nervous system and apolipoprotein E isoform-specific differences, in Research Advances in Alzheimer's Disease and Related Disorders (Iqbal K., Mortimer J. A., Winblad B., and Wisniewski H. M., eds), pp. 385-396. John Wiley & Sons, Chichester.
19. Haass C., Schlossmacher M., Hung A., Vigo-Pelfrey C., Mellon A., Ostaszewski B., Lieberburg I., Koo E., Schenk D., Teplow D., and Selkoe D. J. (1992) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-326.
20. Kounnas M. Z., Loukinova E. B., Stefansson S., Harmony J. A. K., Brewer B. H., Strickland D. K., and Argraves W. S. (1995) Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. J. Biol. Chem. 270, 13070-13075.
21. LaDu M. J., Lukens J. R., Pederson T. M., Reardon C. A., Getz G. S., and Falduto M. T. (1995a) Particle size distribution of native apolipoprotein E in the presence of β-amyloid peptide. Soc. Neurosci. Abstr. 21, 5.
22. LaDu M. J., Pederson T. M., Frail D. E., Reardon C. A., Getz G. S., and Falduto M. T. (1995b) Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid. J. Biol. Chem. 270, 9039-9042.
23. Linton M. F., Gish R., Hubl S. T., Butler E., Esquivel C., Bry W. I., Boyles J. K., Wardell M. R., and Young S. G. (1991) Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J. Clin. Invest. 88, 270-281.
24. Maness L. M., Banks W. A., Podlisny M. B., Selkoe D. J., and Kastin A. J. (1994) Passage of human amyloid-β protein 1-40 across the murine blood-brain barrier. Life Sci. 55, 1643-1650.
25. Mann D. M., Iwatsubo T., Pickering-Brown S. M., Owen F., Saido T. C., and Perry R. H. (1997) Preferential deposition of amyloid β protein (Aβ) in the form Aβ40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele. Neurosci. Lett. 221, 81-84.
26. Martel C. L., Mackic J. B., McComb J. G., Ghiso J., and Zlokovic B. V. (1996) Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid β in guinea pigs. Neurosci. Lett. 206, 157-160.
27. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249.
28. Matsubara E., Frangione B., and Ghiso J. (1995) Characterization of apolipoprotein J-Alzheimer's Aβ interaction. J. Biol. Chem. 270, 7563-7567.
29. Mattson M. P. and Rydel R. E. (1996) Amyloid ox-tox transducers. Nature 382, 674-675.
30. Méresse S., Delbart C., Fruchart J.-C., and Cecchelli R. (1989) Low-density lipoprotein receptor on endothelium of brain capillaries. J. Neurochem. 53, 340-345.
31. Nilsson C., Lindvall-Axelsson M., and Owman C. (1992) Neuroendocrine regulatory mechanisms in the choroid plexus-cerebrospinal fluid system. Brain Res. Rev. 17, 109-138.
32. Poirier J., Delisle M.-C., Quirion R., Aubert I., Farlow M., Lahiri D., Hui S., Bertrand P., Nalbantoglu J., Gilfix B. M., and Gauthier S. (1995) Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc. Natl. Acad. Sci. USA 92, 12260-12264.
33. Polvikoski T., Sulkava R., Haltia M., Kainulainen K., Vuorio A., Vierkkoniemi A., Niinistoe L., Halonen P., and Kontula K. (1995) Apolipoprotein E, dementia, and cortical deposition of β amyloid protein. N. Engl. J. Med. 333, 1242-1247.
34. Premkumar D. R., Cohen D. L., Hedera P., Friedland R. P., and Kalaria R. N. (1996) Apolipoprotein E-∈4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am. J. Pathol. 148, 2083-2095.
35. Prior R., Durso D., Frank R., Prikulis I., Cleven S., Ihl R., and Pavlakovic G. (1996) Selective binding of soluble Aβ1-40 and Aβ1-42 to a subset of senile plaques. Am. J. Pathol. 148, 1749-1756.
36. Rebeck G. W., Harr S. D., Strickland D. K., and Hyman B. T. (1995) Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann. Neural. 37, 211-217.
37. Rubinsztein D. C. (1995) Apolipoprotein E: a review of its roles in lipoprotein metabolism, neuronal growth and repair and as a risk factor for Alzheimer's disease. Psychol. Med. 25, 223-229.
38. Schmechel D. E., Saunders A. M., Strittmatter W. J., Crain B. J., Hulette C. M., Joo S. H., Pericak-Vance M. A., Goldgaber D., and Roses A. D. (1993) Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 9649-9653.
39. Schwarzman A. L., Gregori L., Vitek M. P., Lyubski S., Strittmatter W. J., Enghilde J. J., Bhasin R., Silverman J., Weisgraber K. H., Coyle P. K., and Goldgaber D. (1994) Transthyretin sequesters amyloid β protein and prevents amyloid formation. Proc. Natl. Acad. Sci. USA 91, 8368-8372.
40. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., McCormack R., Wolfert R., Selkoe D. J., Lieberburg I., and Schenk D. (1992) Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359, 325-327.
41. Shoji M., Golde T., Ghiso J., Cheung T., Estus S., Shaffer L., Cai X.-D., McKay D., Tintner R., Frangione B., and Younkin S. (1992) Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258, 126-129.
42. Siest G., Pillot T., Régis-Bailly A., Leininger-Muller B., Steinmetz J., Galteau M.-M., and Visvikis S. (1995) Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin. Chem. 41, 1068-1086.
43. Strittmatter W., Saunders A., Schmecher D., Pericak-Vance M., Enghild J., Salversen G., and Roses A. (1993) Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90, 1977-1981.
44. Strittmatter W. J., Saunders A. M., Goedert M., Weisgraber K. H., Dong L. M., Jakes R., Huang D. Y., Pericak-Vance M., Schmechel D., and Roses A. D. (1994) Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 11183-11186.
45. Suzuki N., Iwatsubo T., Odaka A., Ishibashi Y., Kitada C., and Ihara Y. (1994) High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy. Am. J. Pathol. 145, 452-460.
46. Triguero D., Buciak J., and Pardridge W. M. (1990) Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J. Neurochem. 54, 1882-1888.
47. Vigo-Pelfrey C., Lee D., Keim P., Lieberburg I., and Schenk D. B. (1993) Characterization of β-amyloid peptide from human cerebrospinal fluid. J. Neurochem. 61, 1965-1968.
48. Weisgraber K. H. (1994) Apolipoprotein E: structure-function relationships. Adv. Protein Chem. 45, 249-302.
49. Wisniewski T. and Frangione B. (1992) Apolipoprotein E: a pathologic chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135, 235-238.
50. Wood S. J., Chan W., and Wetzel R. (1996) Seeding of Aβ fibril formation is inhibited by all three isotypes of apolipoprotein E. Biochemistry 35, 12623-12628.
51. Yan S. D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Ster D., and Schmidt A. M. (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691.
52. Yang D. S., Smith J. D., Zhou Z., Gandy S. E., and Martins R. N. (1997) Characterization of the binding of amyloid-β peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma. J. Neurochem, 68, 721-725.
53. Zlokovic B. V. (1995) Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier. Pharmacol. Res. 12, 1395-1406.
54. Zlokovic B. V. (1996) Cerebrovascular transport of Alzheimer's amyloid β and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier. Life Sci. 59, 1483-1497.
55. Zlokovic B. V. (1997) Can blood-brain barrier play a role in the development of cerebral amyloidosis and Alzheimer's disease pathology. Neurobiol. Dis. 4, 23-26.
56. Zlokovic B. V., Ghiso J., Mackic J. B., McComb J. G., Weiss M. H., and Frangione B. (1993) Blood-brain barrier transport of circulating Alzheimer's amyloid β. Biochem. Biophys. Res. Commun. 197, 1034-1040.
57. Zlokovic B. V., Martel C. L., Mackic J. B., Matsubara E., Wisniewski T., McComb J. G., Frangione B., and Ghiso J. (1994) Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid β. Biochem. Biophys. Res. Commun. 205, 1431-1437.
58. Zlokovic B. V., Martel C. L., Matsubara E., McComb J. G., Zheng G., McCluskey R. T., Frangione B., and Ghiso J. (1996) Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid β at the blood-brain and blood-cerebrospinal fluid barriers. Proc. Natl. Acad. Sci. USA 93, 2580-2586.